Chronic Noncancer Pain Rehabilitation With Opioid Withdrawal: Comparison of Treatment Outcomes Based on Opioid Use Status at Admission

Rome, Jeffrey D.; Townsend, Cynthia O.; Bruce, Barbara K.; Sletten, Christopher D.; Luedtke, Connie A.; Hodgson, John E.
June 2004
Mayo Clinic Proceedings;Jun2004, Vol. 79 Issue 6, p759
Academic Journal
• Objective: To study differences in treatment outcomes between patients with chronic noncancer pain taking vs those not taking maintenance opioids at admission to a pain rehabilitation program. • Patients and Methods: A nonrandomized 2-group prepost design was used to compare 356 patients admitted to the Mayo Comprehensive Pain Rehabilitation Center from January 2002 to December 2002 at admission and discharge by opioid status at admission. Measures of pain severity, interference due to pain, perceived life control, affective distress, activity level, depression, and catastrophizing (an exaggerated negative mental set associated with actual or anticipated pain experiences) were used to compare opioid and nonopioid groups. The patients entered a 3-week intensive outpatient multidisciplinary pain rehabilitation program designed to improve adaptation to chronic noncancer pain. The program uses a cognitive-behavioral model and incorporates opioid withdrawal. • Results:More than one third of patients (135/356) were taking opioids daily at admission. At completion of the program, all but 3 of the 135 patients had successfully discontinued opioid treatment. No significant pretreatment differences were found between the opioid and nonopioid group regarding demographics, pain duration, treatment completion, or ail outcome variables, including pain severity. Significant improvement was noted at discharge for all outcome variables assessed regardless of opioid status at admission. • Conclusion: Patients with symptomatically severe and disabling pain while taking maintenance opioid therapy can experience significant improvement in physical and emotional functioning while participating in a pain rehabilitation program that incorporates opioid withdrawal.


Related Articles

  • FOREWORD. Ashburn, Michael // Clinical Drug Investigation;2012 Supplement, Vol. 32 Issue S1, p1 

    No abstract available.

  • Impact of opioid rescue medication for breakthrough pain on the efficacy and tolerability of long-acting opioids in patients with chronic non-malignant pain. Devulder, J.; Jacobs, A.; Richarz, U.; Wiggett, H. // BJA: The British Journal of Anaesthesia;Oct2009, Vol. 103 Issue 4, p576 

    Background: There is little evidence that short-acting opioids as rescue medication for breakthrough pain is an optimal long-term treatment strategy in chronic non-malignant pain. We compared clinical studies of long-acting opioids that allowed short-acting opioid rescue medication with those...

  • Principles of opioid use in chronic noncancer pain. Gardner-Nix, Jacqueline // CMAJ: Canadian Medical Association Journal;7/8/2003, Vol. 169 Issue 1, p38 

    Presents cases on the use of opioid in chronic noncancer pain. Information on the patients presented; Discussion on the diagnosis of pain; Insight on the physiological effect of opioids.

  • COMMENTARY. Eminson, Mary // Evidence Based Medicine;May2003, p89 

    The author discusses aspects of pain management wherein he thinks that psychological therapy is an effective treatment for chronic pain and distress in children and adolescents.

  • Long-term opioid treatment of chronic nonmalignant pain: unproven efficacy and neglected safety? Kissin, Igor // Journal of Pain Research;2013, Vol. 6, p513 

    Background: For the past 30 years, opioids have been used to treat chronic nonmalignant pain. This study tests the following hypotheses: (1) there is no strong evidence-based foundation for the conclusion that long-term opioid treatment of chronic nonmalignant pain is effective; and (2) the main...

  • Study reveals significant misuse of opioids among patients with pain.  // Reactions Weekly;9/5/2009, Issue 1268, p4 

    The article discusses a study on the misuse of opioid among patients with pain. Study authors administered 938,586 urine toxicology tests on more than 500,000 patients who were prescribed opioid analgesics for chronic pain management. They found that only 25 percent of patients had no evidence...

  • Tapentadol extended release in the management of peripheral diabetic neuropathic pain. Vadivelu, Nalini; Kai, Alice; Maslin, Benjamin; Kodumudi, Gopal; Legler, Aron; Berger, Jack M. // Therapeutics & Clinical Risk Management;2015, Vol. 11, p95 

    Tapentadol, a μ-opioid agonist and norepinephrine reuptake inhibitor, has been found to be an effective medication for a wide variety of chronic pain conditions, including back pain, cancer-related pain, and arthritic pain. It has also been found to have fewer gastrointestinal side effects...

  • Versorgungslücke in der Akutschmerztherapie? Gehling, M.; Tryba, M. // Anaesthesist;Oct2013, Vol. 62 Issue 10, p785 

    No abstract available.

  • Treatment of Comorbid Pain with Serotonin Norepinephrine Reuptake Inhibitors. Briley, Mike; Moret, Chantal // CNS Spectrums: The International Journal of Neuropsychiatric Med;Jul2008 Supplement 11, Vol. 13 Issue 7, p22 

    Comorbid chronic pain is common in depressed patients. It is predictive of a poor prognosis for depression and is a major risk factor for suicidal behavior. Depression and chronic pain may result from a common neurobiological dysfunction of monoamine cell bodies in the basal ganglia....


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics